| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Intellia Therapeutics, Inc.'s insiders have reduced their positions by a net 8,111 shares worth roughly $91K. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), NTLA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $12.18M | - | |
| Dir | 207.5K | $2.49M | - | |
| CFO | 148.2K | $1.78M | -8,111 | |
| Dir | 134.7K | $1.62M | - | |
| VP | 121.2K | $1.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Lebwohl David87 | EVP, Chief Medical Officer | Sell | 2,574 | $37.21 | $95,778.54 | -9.1% | -7.5% | -24.6% | |
| Jan 4, 2023 | Goddard Glenn83 | EVP, Chief Financial Officer | Sell | 2,427 | $37.21 | $90,308.67 | -13.6% | -7.5% | -24.6% | |
| Jan 4, 2023 | Basta James72 | EVP, General Counsel | Sell | 1,138 | $37.21 | $42,344.98 | -5.5% | -7.5% | -24.6% | |
| Jan 4, 2023 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 2,028 | $37.65 | $76,356.90 | -4.2% | -7.5% | -24.6% | |
| Jan 1, 2022 | Leonard John M83 | President And CEO | Sale+OE | 2,493 | $112.25 | $279,851.71 | -0.3% | -35.6% | -70.7% | |
| Jan 1, 2022 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sale+OE | 1,148 | $112.25 | $128,863.00 | -19.3% | -35.6% | -70.7% | |
| Jan 1, 2022 | Lebwohl David87 | EVP, Chief Medical Officer | Sale+OE | 1,051 | $112.24 | $117,964.24 | -8.8% | -35.6% | -70.7% | |
| Jan 1, 2022 | Goddard Glenn83 | EVP, Chief Financial Officer | Sale+OE | 1,013 | $112.24 | $113,699.12 | -33.1% | -35.6% | -70.7% | |
| Nov 5, 2021 | Lebwohl David87 | EVP, Chief Medical Officer | Sale+OE | 2,400 | $132.72 | $318,534.60 | -6.1% | -30.2% | -62.4% | |
| Oct 14, 2021 | Lebwohl David87 | EVP, Chief Medical Officer | Sale+OE | 2,400 | $128.44 | $308,249.11 | -4.8% | -25.7% | -60.3% |